Nurix Therapeutics Inc (NRIX)
22.05
-0.32
(-1.43%)
USD |
NASDAQ |
Nov 22, 16:00
21.50
-0.55
(-2.49%)
After-Hours: 20:00
Nurix Therapeutics Debt to Equity Ratio: 0.00 for Aug. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2024 | 0.00 |
| May 31, 2024 | 0.00 |
| February 29, 2024 | 0.00 |
| November 30, 2023 | 0.00 |
| August 31, 2023 | 0.00 |
| May 31, 2023 | 0.00 |
| February 28, 2023 | 0.00 |
| November 30, 2022 | 0.00 |
| August 31, 2022 | 0.00 |
| May 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| February 28, 2022 | 0.00 |
| November 30, 2021 | 0.00 |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| February 29, 2020 | |
| November 30, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Nov 2019
--
Maximum
Nov 2019
--
Average
--
Median
Nov 2019
Debt to Equity Ratio Benchmarks
| Enzo Biochem Inc | 0.0047 |
| Neogen Corp | 0.2836 |
| Pfizer Inc | 0.7219 |
| Zymeworks Inc | 0.00 |
| Accolade Inc | 0.4942 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 513.60M |
| Total Liabilities (Quarterly) | 136.74M |
| Shareholders Equity (Quarterly) | 376.86M |
| Current Ratio | 5.285 |